Company: MDCXW
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001062993-25-006485
Chunk: 445

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 445
---
 Management and Related Stockholder Matters.

Information relating to this item will be included in the proxy statement for our 2025 Annual Meeting of Shareholders and is hereby incorporated by reference in this Annual Report on Form 10-K, unless the Proxy Statement is not filed prior to 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, in which case the information relating to this item will be filed by amendment to this Annual Report on Form 10-K.

Item 13.   Certain Relationships and Related Transactions, and Director Independence.

Information relating to this item will be included in the proxy statement for our 2025 Annual Meeting of Shareholders and is hereby incorporated by reference in this Annual Report on Form 10-K, unless the Proxy Statement is not filed prior to 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, in which case the information relating to this item will be filed by amendment to this Annual Report on Form 10-K.

Item 14.   Principal Accountant Fees and Services.

Information relating to this item will be included in the proxy statement for our 2025 Annual Meeting of Shareholders and is hereby incorporated by reference in this Annual Report on Form 10-K, unless the Proxy Statement is not filed prior to 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, in which case the information relating to this item will be filed by amendment to this Annual Report on Form 10-K.

PART IV

Item 15.   Exhibits, Financial Statement Schedules

(a)  The following documents are filed as part of this Form 10-K:

(1) Financial Statements:

                    Page

                    Report of Independent Registered Public Accounting Firm (PCAOB ID #274)
                    F-2

                    Report of Independent Registered Public Accounting Firm (PCAOB ID #1930)
                    F-3

                    Consolidated Financial Statements
                    F-4

                    Consolidated Balance Sheets
                    F-5

                    Consolidated Statements of Operations and Comprehensive Loss
                    F-6

                    Consolidated Statements of Changes in Shareholders' Equity
                    F-7

                    Consolidated Statements of Cash Flows
                    F-8

(2) Financial Statement Schedules:

None.

(3) Exhibits

We hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits which are